NeuBase Therapeutics Inc (NBSE)
0.42
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
0.42
0.00 (0.00%)
After-Hours: 18:37
NeuBase Therapeutics Free Cash Flow: -14.85M for Sept. 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2023 | -14.85M |
| June 30, 2023 | -19.51M |
| March 31, 2023 | -24.95M |
| December 31, 2022 | -29.83M |
| September 30, 2022 | -29.48M |
| June 30, 2022 | -28.60M |
| March 31, 2022 | -26.34M |
| December 31, 2021 | -21.73M |
| September 30, 2021 | -20.31M |
| June 30, 2021 | -18.45M |
| March 31, 2021 | -14.71M |
| December 31, 2020 | -12.89M |
| September 30, 2020 | -11.43M |
| June 30, 2020 | -8.651M |
| March 31, 2020 | -6.269M |
| December 31, 2019 | -5.341M |
| September 30, 2019 | -3.398M |
| June 30, 2019 | -2.849M |
| March 31, 2019 | -3.326M |
| December 31, 2018 | -5.864M |
| September 30, 2018 | -9.492M |
| June 30, 2018 | -14.17M |
| March 31, 2018 | -17.11M |
| December 31, 2017 | -17.56M |
| September 30, 2017 | -19.30M |
| Date | Value |
|---|---|
| June 30, 2017 | -19.05M |
| March 31, 2017 | -19.12M |
| December 31, 2016 | -18.60M |
| September 30, 2016 | -16.00M |
| June 30, 2016 | -13.18M |
| March 31, 2016 | -10.77M |
| December 31, 2015 | -11.48M |
| September 30, 2015 | -10.88M |
| June 30, 2015 | -10.24M |
| March 31, 2015 | -10.42M |
| December 31, 2014 | -6.806M |
| September 30, 2014 | -5.360M |
| June 30, 2014 | -4.707M |
| March 31, 2014 | -3.488M |
| December 31, 2013 | -3.321M |
| September 30, 2013 | -2.690M |
| June 30, 2013 | -2.285M |
| March 31, 2013 | -1.982M |
| December 31, 2012 | -2.191M |
| September 30, 2012 | -1.787M |
| June 30, 2012 | -1.676M |
| March 31, 2012 | -1.481M |
| December 31, 2011 | -1.099M |
| September 30, 2011 | -1.004M |
| June 30, 2011 | -0.7514M |
Free Cash Flow Range, Past 5 Years
-29.83M
Minimum
Dec 2022
-2.849M
Maximum
Jun 2019
-16.64M
Average
-16.65M
Median
Free Cash Flow Benchmarks
| Ampio Pharmaceuticals Inc | -8.564M |
| Stoke Therapeutics Inc | -82.68M |
| ABVC BioPharma Inc | -4.257M |
| MAIA Biotechnology Inc | -13.07M |
| Aprea Therapeutics Inc | -12.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.003M |
| Cash from Financing (Quarterly) | -0.1745M |
| Free Cash Flow Per Share (Quarterly) | -0.7262 |
| Free Cash Flow Yield | -1.82K% |